search Search
search Search

Media Releases

    • New name, same mission: mylife Diabetes Care AG will continue to innovate for people with diabetes

    mylife Diabetes Care AG will continue to innovate for people with diabetes

    With a legacy of over 40 years in advancing diabetes care, the company will focus entirely on developing innovative automated insulin delivery systems that support people in achieving their goals. Under its new name, mylife Diabetes Care AG will build on its proven strengths and remain true to its purpose: engineering miracles for people with diabetes by combining medical devices and digital technologies.

    ‘‘This name reinforces the link between our company and the people we serve,” said Sébastien Delarive, CEO of mylife Diabetes Care AG. “Driven by science, engineering and dedication, the solutions we develop become life companions to people living with diabetes.’’

    The name change will only be implemented in the coming months in compliance with regulatory requirements.

    Headquartered in Burgdorf, Switzerland, mylife Diabetes Care AG builds on a strong foundation and a highly experienced team to move forward with focus, continuity, and a clear vision – developing integrated, patient-oriented solutions in insulin pump therapy and automated insulin delivery (AID), and empowering people with diabetes through innovation, empathy, and long-term commitment.

    Go back